Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia
Andreas Dammann Andersen, Morten Blaabjerg, Michael Binzer, Akram Kamal, Helle Thagesen, Troels Wesenberg Kjaer, Egon Stenager, Jan Bert Paul Gramsbergen
Dyk ned i forskningsemnerne om 'Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia'. Sammen danner de et unikt fingeraftryk.